More Australian Clinical Labs Ltd news
Australian Clinical Labs LtdASX: ACL

Upgrade to 1H FY22 Pro Forma Expectations

Dec 20, 2021 at 9:41 PM EST · Issued by Australian Clinical Labs Ltd

Filed with ASX · Dec 20, 2021 at 9:41 PM EST

On 6ix: 6ix.com/news/upgrade-to-1h-fy22-pro-forma-expectations

Australian Clinical Labs Ltd has released a press release.

View Attachment

6ix hasn’t read this filing yet.

Australian Clinical Labs Ltd on 6ix

Earlier from Australian Clinical Labs

  • Completion of Medlab AcquisitionDec 19, 2021
  • Medlab Pathology - Investor PresentationNov 14, 2021
  • Acquisition of Medlab Pathology by ACLNov 14, 2021
  • 2021 AGM addresses and 1H22 trading updateOct 26, 2021
  • 1H FY22 Updated Profit GuidanceSep 27, 2021

Later from Australian Clinical Labs

  • Letter from Crescent Capital PartnersDec 21, 2021
  • Appendix 4DFeb 23, 2022
  • 1H22 Investor PresentationFeb 23, 2022
  • Media Release - 1H22 Financial ResultsFeb 23, 2022
  • Establishment of Dividend Reinvestment PlanFeb 23, 2022
All Australian Clinical Labs news releases↗

Follow Australian Clinical Labs into a list and get an email when it puts out news.

Follow Australian Clinical Labs
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer